| 规格 | 价格 | 库存 |
|---|---|---|
| 100µL | ¥ 4928 | 1 |
ICC - Quality tested
IHC-P, ICFC, 3D IHC - Verified
SB - Reported in the literature, not verified in house
Each lot of this antibody is quality control tested by immunocytochemistry. For immunocytochemistry, a dilution of 1:500 is recommended. For immunohistochemistry, a concentration range of 1.0 - 5.0 ?g/ml is suggested.?For flow cytometric staining, the suggested use of this reagent is 5 ?L per million cells in 100 ?L staining volume or 5 ?L per 100 ?L of whole blood. For 3D immunohistochemistry on formalin-fixed tissues, a concentration of 5.0 ?g/mL is suggested. It is recommended that the reagent be titrated for optimal performance for each application.
Additional reported applications (for the relevant formats) include: flow cytometry4, immunofluorescence microscopy1-5,7, immunohistochemistry5,7,?Western blotting8, and spatial biology (IBEX)9,10.
This antibody is well characterized and highly reactive to neuron specific Class III ?-tubulin (?III). TUJ1 does not identify ?-tubulin found in glial cells. TUJ1 recognizes an epitope located within the last 15 C-terminal residues8.
Iterative Bleaching Extended multi-pleXity (IBEX) is a fluorescent imaging technique capable of highly-multiplexed spatial analysis. The method relies on cyclical bleaching of panels of fluorescent antibodies in order to image and analyze many markers over multiple cycles of staining, imaging, and, bleaching. It is a community-developed open-access method developed by the Center for Advanced Tissue Imaging (CAT-I) in the National Institute of Allergy and Infectious Diseases (NIAID, NIH).
Covered by US patents 5,675,063 and 7,429,487. Sold under license from Epitomics.
Tissue distribution: central and peripheral nervous system.
Cellular distribution: cytosol, cytoskeleton and nucleus.
1. Zhao X,?et al.?2017. Med Sci Monit. 22: 3915.
2.?Lebok P,?et al. 2016. Oncol Lett. 11(3):1987.
3. Du J,?et al.?2015. BMC Cancer. 15:536.?PubMed
4.?Rogue DM.,?et al. 2013. Clin Exp Metastasis. 31(1): 101.
5.?Ploussard G,?et al.?2010. Cancer Res. 70(22):9253.?PubMed